All 2023 SS presentations
View another way?
D1-1 Welcome, Scope, and Utility of Program - Day 1
Welcome, Scope, and Utility of Program - Day 1Presented by Robert Francois Hobbs, PhD, Johns Hopkins University
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 17444

D1-2 Current FDA-Approved RPTs and their Use
Current FDA-Approved RPTs and their UsePresented by Nikki Maughan , Washington University in St. Louis
This presentation has an average satisfaction 5.0 (higher is better), with 1 responding
VLID: 17446

D1-3 Regulatory, Medical Events
Regulatory, Medical EventsPresented by Katie Tapp , Nuclear Regulatory Commission
This presentation has an average satisfaction 5.0 (higher is better), with 1 responding
VLID: 17448

D1-4 Physician Perspective
Physician PerspectivePresented by Chaitanya Divgi
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 17450

D1-5 Release Criteria vs. Take Home Instructions
Release Criteria vs. Take Home InstructionsPresented by Wes E. Bolch, PhD, University of Florida
This presentation has an average satisfaction 5.0 (higher is better), with 1 responding
VLID: 17434

D1-6 Receiving and Waste Disposal
Receiving and Waste DisposalPresented by Jessica Clements, MS, University of Vermont Medical Center
This presentation has an average satisfaction 5.0 (higher is better), with 2 responding
VLID: 17436

D1-7 Professional Economics
Professional EconomicsPresented by Russell Blaine Tarver, MS, The Center for Cancer and Blood Disorders
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 17438

D2-1 SPECT/CT Quantification
SPECT/CT QuantificationPresented by Eric C. Frey, PhD, Johns Hopkins University
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 17460

D2-2 PET and Radiopharmaceutical Therapy: Clinical Physics Establishing a Sound Foundation for Quantitative Accuracy
PET and Radiopharmaceutical Therapy: Clinical Physics Establishing a Sound Foundation for Quantitative AccuracyPresented by Josh M. Wilson, PhD, Duke University Health System
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 17462

D2-3 PET/CT Quantification
PET/CT QuantificationPresented by Denis Bergeron , National Institute of Standards and Tech
This presentation has an average satisfaction 4.0 (higher is better), with 1 responding
VLID: 17464

D2-4 Dose Calibrator QA, Traceability, and Uncertainty
Dose Calibrator QA, Traceability, and UncertaintyPresented by Denis Bergeron , National Institute of Standards and Tech
This presentation has an average satisfaction 5.0 (higher is better), with 2 responding
VLID: 17452

D2-5 Phantom Preparation Calibration/Sensitivity Factor
Phantom Preparation Calibration/Sensitivity FactorPresented by Eric C. Frey, PhD, Johns Hopkins University
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 17454

D2-6 Machine QA - Transitioning to Therapy
Machine QA - Transitioning to TherapyPresented by Stephen A. Graves, PhD, University of Iowa
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 17456

D3-1 Principles of Prospective Treatment Planning
Principles of Prospective Treatment PlanningPresented by Joseph Steiner, PhD, University of Minnesota Medical Center
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 17478

D3-2 MIRD Applied: Whole Organ Dosimetry and Phantoms
MIRD Applied: Whole Organ Dosimetry and PhantomsPresented by Wes E. Bolch, PhD, University of Florida
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 17480

D3-3 MIRD Applied: Y-90 Microspheres - Partition ""Model"
MIRD Applied: Y-90 Microspheres - Partition ""Model""Presented by Diane Alvarez, MS, Miami Cancer Institute
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 17482

D3-4 Curve Fitting - Time Point and Fit Choices, Extrapolation
Curve Fitting - Time Point and Fit Choices, ExtrapolationPresented by Joseph A. O'Donoghue , Memorial Sloan Kettering Cancer Center
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 17466

D3-5 Uncertainties and Error Propagation
Uncertainties and Error PropagationPresented by Jonathan Gear , Institute of Cancer Research & The Royal Marsden NHS Foundation Trust
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 17468

D3-6 Surrogate Imaging - Time Points and Decay Correction
Surrogate Imaging - Time Points and Decay CorrectionPresented by Adam Leon Kesner , Memorial Sloan Kettering Cancer Center
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 17470

D4-1 Principles of Voxelized Dosimetry
Principles of Voxelized DosimetryPresented by Stephen A. Graves, PhD, University of Iowa
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 17496

D4-2 Registration Choices and 3D Dose Maps
Registration Choices and 3D Dose MapsPresented by Bryan Bednarz, PhD, University of Wisconsin
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 17498

D4-3 Uncertainties and Relative Merits of Voxelized Dosimetry vs. MIRD Method
Uncertainties and Relative Merits of Voxelized Dosimetry vs. MIRD MethodPresented by Jonathan Gear , Institute of Cancer Research & The Royal Marsden NHS Foundation Trust
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 17500

D4-4 Bio-Effect Modeling, Standardization and Applicability, MTD, and EBRT Equivalence, Combinations
Bio-Effect Modeling, Standardization and Applicability, MTD, and EBRT Equivalence, CombinationsPresented by Robert Francois Hobbs, PhD, Johns Hopkins University
This presentation has an average satisfaction 5.0 (higher is better), with 1 responding
VLID: 17484

D4-5 Standardization and ICRU 96
Standardization and ICRU 96Presented by Roger W. Howell, PhD, Rutgers New Jersey Medical School
This presentation has an average satisfaction 4.0 (higher is better), with 1 responding
VLID: 17486

D4-6 Single-Time Point Dosimetry: Pros and Cons
Single-Time Point Dosimetry: Pros and ConsPresented by Robert Francois Hobbs, PhD, Johns Hopkins University
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 17488

D5-1 Potential Sources of Error: SNMIMI Challenge and/or IAEA CRP Results
Potential Sources of Error: SNMIMI Challenge and/or IAEA CRP ResultsPresented by Robert Francois Hobbs, PhD, Johns Hopkins University
This presentation has an average satisfaction 5.0 (higher is better), with 1 responding
VLID: 17506

D5-2 Double Checks, QA, Intermediate Results and Consistency
Double Checks, QA, Intermediate Results and ConsistencyPresented by Rachel Barbee , MD Anderson Cancer Center
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 17508

D5-3 Closing Statements
Closing StatementsPresented by Robert Francois Hobbs, PhD, Johns Hopkins University
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 17502